Leishmaniasis
- PMID: 17068275
- PMCID: PMC2653905
- DOI: 10.1136/pgmj.2006.047340
Leishmaniasis
Corrected and republished in
-
Leishmaniasis.Postgrad Med J. 2007 Feb;83(976):649-57. doi: 10.1136/pgmj.2006.047340corr1. Postgrad Med J. 2007. PMID: 17396274 Free PMC article. Review.
Abstract
Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity of this infection, and new diagnostic tests that are helping better diagnosis, especially in resource-poor areas. Other important aspects discussed include the potential for newer oral treatment to change the way this disease is managed; leishmania-HIV coinfection and groups at risk; and the development of an effective vaccine.
Conflict of interest statement
Competing interests: None.
References
-
- Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004. 27 305 318 - PubMed
-
- Murray H W. Kala‐azar‐progress against a neglected disease. N Engl J Med 2002. 22 347, 1793 347, 1794 - PubMed
-
- Guerin P J, Olliaro P, Sundar S. et al Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002. 2 494 501 - PubMed
-
- Herwaldt B L. Leishmaniasis. Lancet 1999. 354 1191 1199 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical